Literature DB >> 34328104

The mechanisms of renin-angiotensin system in hepatocellular carcinoma: From the perspective of liver fibrosis, HCC cell proliferation, metastasis and angiogenesis, and corresponding protection measures.

Hai-Feng Zhang1, Xiang Gao1, Xuan Wang2, Xin Chen2, Yu Huang1, Lang Wang1, Zhou-Wei Xu3.   

Abstract

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, of which the occurrence and development involve a variety of pathophysiological processes, such as liver fibrosis, hepatocellular malignant proliferation, metastasis, and tumor angiogenesis. Some important cytokines, such as TGF-β, PI3K, protein kinase B (Akt), VEGF and NF-κB, can regulate the growth, proliferation, diffusion, metastasis, and apoptosis of HCC cells by acting on the corresponding signaling pathways. Besides, many studies have shown that the formation of HCC is closely related to the main components of renin-angiotensin system (RAS), such as Ang II, ACE, ACE2, MasR, AT1R, and AT2R. Therefore, this review focused on liver fibrosis, HCC cell proliferation, metastasis, tumor angiogenesis, and corresponding protective measures. ACE-Ang II-AT1 axis and ACE2-Ang-(1-7)-MasR axis were taken as the main lines to introduce the mechanism of RAS in the occurrence and development of HCC, so as to provide references for future clinical work and scientific research.
Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Cell Proliferation; Hepatocellular carcinoma; Liver Fibrosis; Renin–Angiotensin System

Mesh:

Year:  2021        PMID: 34328104     DOI: 10.1016/j.biopha.2021.111868

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  4 in total

Review 1.  Renin-Angiotensin System in Liver Metabolism: Gender Differences and Role of Incretins.

Authors:  Zainab Mastoor; Yolanda Diz-Chaves; Lucas C González-Matías; Federico Mallo
Journal:  Metabolites       Date:  2022-05-03

2.  The non-coding RNA (ncRNA)-mediated high expression of polycomb group factor 1 (PCGF1) is a prognostic biomarker and is correlated with tumor immunity infiltration in liver hepatocellular carcinoma.

Authors:  Junning Liu; Yingxun Xu; Chengcai Sun; Shiwei Yang; Jian Xie; Hrishikesh Samant; Xuezhi Xin
Journal:  Ann Transl Med       Date:  2022-08

3.  Integrated analysis to study the interplay between post-translational modifications (PTM) in hepatitis C virus proteins and hepatocellular carcinoma (HCC) development.

Authors:  Aqsa Ikram; Bisma Rauff; Badr Alzahrani; Faryal Mehwish Awan; Ayesha Obaid; Anam Naz; Salik Javed Kakar; Hussnain Ahmed Janjua
Journal:  Sci Rep       Date:  2022-09-19       Impact factor: 4.996

4.  System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma.

Authors:  Cheng Yan; Yandie Niu; Liukai Ma; Lifang Tian; Jiahao Ma
Journal:  J Transl Med       Date:  2022-10-04       Impact factor: 8.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.